164 related articles for article (PubMed ID: 37448256)
21. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report.
She WH; Chok KSH; Li IWS; Ma KW; Sin SL; Dai WC; Fung JYY; Lo CM
BMC Infect Dis; 2019 Jan; 19(1):66. PubMed ID: 30658592
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
23. Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia.
Beale F; Gkiourtzis N; Koneru S; O'Brien C; Lalayiannis AD
Pediatr Nephrol; 2024 Aug; 39(8):2355-2358. PubMed ID: 38277030
[TBL] [Abstract][Full Text] [Related]
24. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
[TBL] [Abstract][Full Text] [Related]
25. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
Yang P; Zhu X; Liang W; Cai R
Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
[TBL] [Abstract][Full Text] [Related]
26. Pneumocystis jirovecii pneumonia: a case report.
Gri J; Jain V
J Med Case Rep; 2024 Feb; 18(1):52. PubMed ID: 38342895
[TBL] [Abstract][Full Text] [Related]
27. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
28. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
29. [A case of Pneumocystis jirovecii pneumonia after kidney transplantation with re-exacerbation following therapy].
Hirai J; Haranaga S; Teruya H; Yara S; Higa F; Fujita J
Nihon Kokyuki Gakkai Zasshi; 2011 May; 49(5):365-70. PubMed ID: 21688645
[TBL] [Abstract][Full Text] [Related]
30.
Takahashi T; Saito A; Kuronuma K; Nishikiori H; Chiba H
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143828
[TBL] [Abstract][Full Text] [Related]
31. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.
Chen RY; Li DW; Wang JY; Zhuang SY; Wu HY; Wu JJ; Qu JW; Sun N; Zhong C; Zhu C; Zhang M; Yu YT; Yuan XD
Int J Infect Dis; 2022 Dec; 125():209-215. PubMed ID: 36243280
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia associated with
Coche S; Cornet G; Morelle J; Labriola L; Kanaan N; Demoulin N
Acta Clin Belg; 2021 Feb; 76(1):75-78. PubMed ID: 31470765
[No Abstract] [Full Text] [Related]
34. Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients.
Xu J; Yu Y; Lv J; Yang S; Wu J; Chen J; Peng W
Ann Transplant; 2021 Jun; 26():e931059. PubMed ID: 34099614
[TBL] [Abstract][Full Text] [Related]
35. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
[TBL] [Abstract][Full Text] [Related]
36. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
Sarwar S; Carey B; Hegarty JE; McCormick PA
Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
[TBL] [Abstract][Full Text] [Related]
37. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
38. [Severe hypoxemic respiratory failure caused by Pneumocystis jirovecii in a late kidney transplant recipient].
Nieto-Ríos JF; Zuluaga-Quintero M; Aristizábal-Alzate A; Ocampo-Kohn C; Serna-Higuita LM; Ramírez-Sánchez IC; Zuluaga-Valencia GA
Biomedica; 2018 Mar; 38(1):32-36. PubMed ID: 29668131
[TBL] [Abstract][Full Text] [Related]
39. Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient.
Li JY; Yong TY; Grove DI; Coates PT
Clin Exp Nephrol; 2009 Feb; 13(1):92-5. PubMed ID: 18758701
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.
Peng J; Ni M; Du D; Lu Y; Song J; Liu W; Shen N; Wang X; Zhu Y; Vallance BA; Sun Z; Yu HB
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):83. PubMed ID: 34911528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
